The Federal Court has upheld Novartis’ appeal of a ruling revoking its patent for an oral form of multiple sclerosis drug Gilenya, after Australian generic […]
Intellectual Property
2020-10-12 2:35 pm
| Sydney
The Federal Court has upheld Novartis’ appeal of a ruling revoking its patent for an oral form of multiple sclerosis drug Gilenya, after Australian generic […]
For information on rights and reprints, contact subscriptions@lawyerly.com.au